Patents by Inventor Arthur K. Field

Arthur K. Field has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4880820
    Abstract: (S)-9-(2,3-dihydroxy-1-propoxymethyl)guanine has potent antiherpetic activity which is superior to the corresponding racemic mixture or the (R)-enantiomer and also is much more potent than 9-(2-hydroxyethoxymethyl)guanine. Acyl derivatives (prodrugs) of the (S)-enantiomer, which are more effective than the corresponding (R)-enantiomer analogs or related racemic mixtures provide formulation advantages and even higher plasma half lives in animals or man than the (S)-isomer.
    Type: Grant
    Filed: February 8, 1988
    Date of Patent: November 14, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Wallace T. Ashton, Laura F. Canning, Arthur K. Field, Richard L. Tolman
  • Patent number: 4816447
    Abstract: 9-(1,3-Dihydroxy-2-propoxymethyl)guanine and 9-(2,3-dihydroxy-1-propoxymethyl)guanine have been found to have potent anti-viral activity against herpes viruses. These compounds, their acyl derivatives, their phosphate derivatives and their pharmaceutically acceptable salts, pharmaceutical formulations containing these compounds, the treatment of DNA viral or herpes viral infections with these compounds, method of preparing these compounds, and novel intermediates useful in their preparation are all disclosed.The compounds may be prepared by reaction of the appropriate acetoxymethyl ether with diacetylguanine, followed by deprotection. The acetoxymethyl ethers may be obtained by reaction of glycerol formal with acetic anhydride in the presence of a catalyst.
    Type: Grant
    Filed: June 6, 1984
    Date of Patent: March 28, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Wallace T. Ashton, Arthur K. Field, John D. Karkas, Richard L. Tolman
  • Patent number: 4283393
    Abstract: Virus infections of eye, skin and mucous membrane tissue are effectively treated by controlled release topical application of interferon inducers.
    Type: Grant
    Filed: March 13, 1979
    Date of Patent: August 11, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Arthur K. Field, Richard J. Harwood
  • Patent number: 4198479
    Abstract: The invention provides an improved process for the growth of lymphoblastoid cells in a medium supplemented with human albumin. The invention further provides for the production of interferon by viral infection of these lymphoblastoid cells in a medium also supplemented with human albumin. This invention eliminates the necessity for adding animal proteins.
    Type: Grant
    Filed: March 30, 1979
    Date of Patent: April 15, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Alfred A. Tytell, Edgar Scattergood, Arthur K. Field
  • Patent number: 4124702
    Abstract: Polynucleotides which are multistranded are active as inducers of interferon production in living animal cells. They may be:A. Synthetically complexed polymers of two homopolynucleotides.B. A nucleic acid released by phenol from a ribonucleic acid complex elaborated by the growth of Penicillium funiculosum.C. A ribonucleic acid from reovirus type 3 virions.D. Replicative forms of nucleic acids.
    Type: Grant
    Filed: December 14, 1976
    Date of Patent: November 7, 1978
    Assignee: Merck & Co., Inc.
    Inventors: George P. Lampson, Alfred A. Tytell, Arthur K. Field, Maurice R. Hilleman